A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.


Updates from The Motley Fool

Latest updates on StemCells from Fool.com.


Stock Performance

STEM vs. S&P 500 | 2 Year Performance
View Interactive STEM Charts
Sponsored by

Key Data Points

Primary metrics and data points about StemCells.
Current Price: $1.39
Prev Close: $1.40
Open: $1.39
Bid: $1.37
Ask: $1.41
Day's Range: $1.37 - $1.41
52wk Range: $0.33 - $7.56
Volume: 342,801
Avg Vol 5,919,476
Market Cap: $151.24M
P/E (ttm): -0.53
EPS (ttm): -$2.62
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about StemCells.
CAPS Rating 1 out of 5
 
440 Outperform
65 Underperform
CAPS All Stars
 
58 Outperform
20 Underperform

How do you think StemCells will perform against the market?



You pick for StemCells is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Martin M. McGlynn, CEO

0% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for StemCells.

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers